260 related articles for article (PubMed ID: 17607190)
1. [Immunosuppression with monoclonal antibodies in multiple sclerosis].
Vermersch P; Zéphir H
Rev Neurol (Paris); 2007 Jun; 163(6-7):682-7. PubMed ID: 17607190
[TBL] [Abstract][Full Text] [Related]
2. Natalizumab for relapsing remitting multiple sclerosis.
Pucci E; Giuliani G; Solari A; Simi S; Minozzi S; Di Pietrantonj C; Galea I
Cochrane Database Syst Rev; 2011 Oct; (10):CD007621. PubMed ID: 21975773
[TBL] [Abstract][Full Text] [Related]
3. Natalizumab (Tysabri) treatment for relapsing multiple sclerosis.
Johnson KP
Neurologist; 2007 Jul; 13(4):182-7. PubMed ID: 17622909
[TBL] [Abstract][Full Text] [Related]
4. Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.
Rudick RA; Stuart WH; Calabresi PA; Confavreux C; Galetta SL; Radue EW; Lublin FD; Weinstock-Guttman B; Wynn DR; Lynn F; Panzara MA; Sandrock AW;
N Engl J Med; 2006 Mar; 354(9):911-23. PubMed ID: 16510745
[TBL] [Abstract][Full Text] [Related]
5. Multiple sclerosis, natalizumab therapy, and progressive multifocal leukoencephalopathy.
Bartt RE
Curr Opin Neurol; 2006 Aug; 19(4):341-9. PubMed ID: 16914971
[TBL] [Abstract][Full Text] [Related]
6. Natalizumab: new drug. Multiple sclerosis: risky market approval.
Prescrire Int; 2008 Feb; 17(93):7-10. PubMed ID: 18354844
[TBL] [Abstract][Full Text] [Related]
7. Natalizumab for induction of remission in Crohn's disease.
Macdonald JK; McDonald JW
Cochrane Database Syst Rev; 2006 Jul; (3):CD006097. PubMed ID: 16856112
[TBL] [Abstract][Full Text] [Related]
8. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.
Polman CH; O'Connor PW; Havrdova E; Hutchinson M; Kappos L; Miller DH; Phillips JT; Lublin FD; Giovannoni G; Wajgt A; Toal M; Lynn F; Panzara MA; Sandrock AW;
N Engl J Med; 2006 Mar; 354(9):899-910. PubMed ID: 16510744
[TBL] [Abstract][Full Text] [Related]
9. Natalizumab and the role of alpha 4-integrin antagonism in the treatment of multiple sclerosis.
O'Connor P
Expert Opin Biol Ther; 2007 Jan; 7(1):123-36. PubMed ID: 17150024
[TBL] [Abstract][Full Text] [Related]
10. Natalizumab for induction of remission in Crohn's disease.
MacDonald JK; McDonald JW
Cochrane Database Syst Rev; 2007 Jan; (1):CD006097. PubMed ID: 17253580
[TBL] [Abstract][Full Text] [Related]
11. [Biological treatment of multiple sclerosis].
Sørensen PS; Sellebjerg F
Ugeskr Laeger; 2008 Jun; 170(24):2156-9. PubMed ID: 18565303
[TBL] [Abstract][Full Text] [Related]
12. The role of natalizumab in the treatment of multiple sclerosis.
Coyle PK
Am J Manag Care; 2010 Jun; 16(6 Suppl):S164-70. PubMed ID: 20615052
[TBL] [Abstract][Full Text] [Related]
13. [Current treatment of multiple sclerosis].
Gout O; Bensa C; Assouad R
Rev Med Interne; 2010 Aug; 31(8):575-80. PubMed ID: 20579785
[TBL] [Abstract][Full Text] [Related]
14. [Natalizumab in the treatment of multiple sclerosis].
Horga A; Horga de la Parte JF
Rev Neurol; 2007 Sep 1-15; 45(5):293-303. PubMed ID: 17876741
[TBL] [Abstract][Full Text] [Related]
15. A controlled trial of natalizumab for relapsing multiple sclerosis.
Miller DH; Khan OA; Sheremata WA; Blumhardt LD; Rice GP; Libonati MA; Willmer-Hulme AJ; Dalton CM; Miszkiel KA; O'Connor PW;
N Engl J Med; 2003 Jan; 348(1):15-23. PubMed ID: 12510038
[TBL] [Abstract][Full Text] [Related]
16. Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study.
Havrdova E; Galetta S; Hutchinson M; Stefoski D; Bates D; Polman CH; O'Connor PW; Giovannoni G; Phillips JT; Lublin FD; Pace A; Kim R; Hyde R
Lancet Neurol; 2009 Mar; 8(3):254-60. PubMed ID: 19201654
[TBL] [Abstract][Full Text] [Related]
17. Natalizumab and progressive multifocal leukoencephalopathy: migrating towards safe adhesion molecule therapy in multiple sclerosis.
Bennett JL
Neurol Res; 2006 Apr; 28(3):291-8. PubMed ID: 16687056
[TBL] [Abstract][Full Text] [Related]
18. Natalizumab: a review of its use in the management of relapsing-remitting multiple sclerosis.
McCormack PL
Drugs; 2013 Sep; 73(13):1463-81. PubMed ID: 23912625
[TBL] [Abstract][Full Text] [Related]
19. [Blocking adhesion molecules with natalizumab in multiple sclerosis].
Schreiner B; Kieseier BC; Hartung HP; Hohlfeld R; Wiendl H
Nervenarzt; 2005 Aug; 76(8):999-1005. PubMed ID: 15812675
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies in the treatment of multiple sclerosis.
Di Pauli F; Berger T; Reindl M
Curr Med Chem; 2009; 16(36):4858-68. PubMed ID: 19929782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]